Keloid Treatment Market
Keloid Treatments: Unique and Minimally Invasive Treatment Approaches That Don’t Let Keloids Scar Your Skin and Confidence! Find Out More with FMI
Keloid Treatment Market by Treatment, End User & Region - Forecast 2022 – 2032
Keloid Treatment Market Outlook (2022-2032)
[250 Pages Report] The global keloid treatment market size reached US$ 3.6 Bn in 2021 and is expected to enjoy a valuation of US$ 3.7 Bn by the end of 2022. Furthermore, with rising prevalence of keloid across the world, the overall demand for keloid treatment is set to grow at 3.2% CAGR between 2022 and 2032, totalling a valuation of ~US$ 5.1 Bn by 2032.
Among various types of treatments, the intralesional corticosteroid injections segment dominated the global keloid treatment market with a share of about 28.3% in 2021 and the trend is likely to continue during the forecast period.
|
Attribute |
Key Statistics |
|
Keloid Market Base Value (2021) |
US$ 3.6 Bn |
|
Estimated Market Value (2022) |
US$ 3.7 Bn |
|
Projected Market Value (2032) |
US$ 5.1 Bn |
|
Value-based CAGR (2022-2032) |
3.2% |
|
Market Share of Top 5 Countries |
60.7% |
Keloids and hypertrophic scars are caused by cutaneous injury and irritation, including trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection.
Scars can be treated in a variety of ways with varying degrees of success. Nonsurgical treatments, which aim to slow the appearance of scars, enhance their looks, and restore function, have grown to be of utmost importance.
Factors such as increase in the number of road accidents and burn cases, advancements in keloid treatment approaches, and rising popularity of aesthetic surgeries are playing crucial roles in accelerating the growth of keloid treatment market.
The keloid treatment market formed approximately 29.5% of the overall ~US$ 14.1 Bn global scar treatment market in 2021 and this number is likely to further increase during the forecast period.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Keloid Treatment from 2012 to 2021 Vs Market Outlook for 2022 to 2032
The global sales of keloid treatment are projected to grow at 3.2% CAGR between 2022 and 2032, in comparison to 3.5% CAGR registered during the historical period of 2012 to 2021. Increasing incidence of wound and injury-related cases, rising number of aesthetic surgeries being performed worldwide, and growing adoption of various keloid treatments are some of the key factors expected to drive growth in the global market.
Similarly, rising preference for minimally invasive procedures will further accelerate the growth of keloid treatment market during the next ten years.
Clinicians have assessed the potential of anti-inflammatory and chemotherapeutic molecules to inhibit keloid recurrence in addition to conducting studies to enhance the use of conventional therapies, such as steroids and radiation. Cryotherapy and lasers, two procedure-focused therapies, have also been demonstrated to be effective in lowering keloid symptomatology.
Keloids are distinguished as being more clinically severe in nature than hypertrophic scars, commonly causing itching and pain in patients. In contrast to hypertrophic scars, which can heal naturally over years, keloids grow to produce thick, stiff scars that seldom heal on their own. The fundamental elements of keloid pathogenesis have attracted a lot of attention since keloids can be distressing for patients.
The variety of therapy available for the prevention and treatment of keloids is constantly growing, and optimistic technological breakthroughs from innovative methodologies have contributed to this growth. Reliable information about the consistent use of the various injectable therapies and devices reported in the literature can be collected as doctors get more experience using them.
There are currently no accepted standards for keloid management that have the approval of an academic governing body. As a result, there are many prospects for research and development of treatment modalities to provide a variety of treatments for keloids as a standardized measure of care in the market for keloid treatment.
Thus, increasing investments in R&D in this sphere is expected to create lucrative growth opportunities for leading providers during the forecast period.
What are the Key Trends Driving the Keloid Treatment Market?
“Advancements in Keloid Treatments to Present an Array of Opportunities for Market Growth”
In addition to the already available conventional treatment options, improvements in the knowledge of the molecular mechanisms underlying keloids and hypertrophic scars have ushered in a new age of drug discovery and the development of novel, emerging anti-pathologic scar treatments.
Interferons, which have shown great success in treating high-risk melanomas, are one of a few emerging treatments that are widely used in a variety of skin conditions like condyloma acuminate and basal cell carcinoma.
Verapamil, an antihypertensive medication, works on keloids and hypertrophic scars by lowering calcium levels inside the cells. For patients with keloids, autologous fat grafting (also known as lipotransfer) of adipose tissue-derived stem cells (ADSCs) has been proven to enhance scar texture, pliability volume, and elasticity.
Mesenchymal stem cells (MSCs) have shown a strong ability to enhance healing of wounds and regeneration by secreting differentiation and growth factors that promote migration, angiogenesis, and up-regulate epithelialization and collagen remodeling.
Over the projected years, market participants will have access to a wide range of profitable growth prospects due to the availability of treatments for keloids.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Growth of Keloid Treatment Market?
Many therapeutic approaches have been explored for the prevention and reduction of keloids and hypertrophic scars, but none of them are beneficial in all patients. There is currently no recognized global standard of care for treatment, and the evidence-based literature is limited.
Keloid and hypertrophic scars are a constant issue for patients and clinicians, despite the many targeted options that are currently available. No one therapy has, as of now, been regarded as the gold standard for all excessive scarring, nor has it been able to eliminate scarring. These factors will therefore continue to have a negative impact on the overall market growth.
Country-wise Insights
Will the U.S. Continue to Retain its Dominant Position in North American Keloid Treatment Market?
“Rise in Cases of Burn Injuries and Road Accidents to Bolster Market Growth in the U.S.”
The U.S. dominated North American keloid treatment market in 2021 with a total market share of about 88.0% and is expected to continue to experience the same growth throughout the forecast period.
Growth in the U.S. keloid treatment market is driven by rising prevalence of accidents, injuries, as well as dermal illnesses, presence of highly sophisticated healthcare facilities, and high levels of healthcare awareness among people.
According to a report published in 2016 by the American Burn Association, there were around 486,000 burn injury cases reported in the U.S that received medical treatment. This rise in burn accidents is expected to foster the growth of keloid treatment in the country during the assessment period.
What is the Demand Outlook for Keloid Treatment Market in Germany?
“Booming Medical Tourism Pushing Demand for Keloid Treatments in Germany”
As per FMI, the keloid treatment market in Germany is set to exhibit a CAGR of nearly 4.5% during the forecast period owing to the flourishing medical tourism, presence of advanced equipment for dermatology and cosmetic procedures, and increasing spending by people on cosmetic procedures.
Similarly, rapid expansion of healthcare industry and increasing prevalence of keloid disorder among the German population will bode well for the keloid market during the assessment period.
How is Keloid Treatment Market Shaping Up in China?
“Increasing Investments in R&D to Supplement Market Growth in China”
China held a market share of around 9.1% in the global keloid treatment market in 2021 and it is anticipated to witness a steady growth rate during the forecast period. There are vast developments in research-based activities within the country, and this factor is expected to provide traction to the overall market growth.
Moreover, with a high population density and favourable government support, the country is expected to provide a large share of revenue within the global keloid treatment market, throughout the forecast years.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which is the Most Popular Treatment for Keloid?
“Intralesional Corticosteroid Injections Will Remain the Most Preferred Treatment for Keloid”
As per FMI, the intralesional corticosteroid injections segment is expected to grow at the highest CAGR of 2.5% between 2022 and 2032, accounting for a market share of about 26.3% in the global keloid treatment market in 2032. This can be attributed to the rising preference of patients for opting for intralesional corticosteroid injections due to their higher effectiveness.
The most often used treatment option for keloid scars is the intralesional injection, preferably separately or in combination with 5-FU, verapamil, and bleomycin. In the nonsurgical treatment of hypertrophic and keloid scars, it is considered to be the gold standard.
Which End User Contributes Most to the Global Keloid Treatment Market?
“Demand for Keloid Treatment to Remain High in Hospitals”
Hospitals segment held the highest market share value of around 37.0% in 2021 and is poised to grow at a higher growth rate during the assessment period. This can be attributed to the rising number of hospitals across the world and easy availability of various keloid treatments at lower prices in government hospitals.
Similarly, rising inclination of patients to opt for keloid treatments in hospitals due to presence of well-trained medical professionals will bode well for the market growth during the forecast period.
Competitive Landscape
The keloid treatment market is highly fragmented due to the presence of numerous rivals in this space. Leading businesses are employing strategies including mergers and acquisitions, alliances and collaborations, and new product releases to satisfy consumer demand and increase their client base.
Some of the recent developments in keloid treatment market are listed below:
- Two Singapore approvals of Sonoma Pharmaceuticals' Microcyn® (hypochlorous acid) for the treatment of atopic dermatitis and hypertrophic / keloid scars were announced in June 2017.
- The RECELL® System for the treatment of acute burns was covered by insurance in Japan, according to an announcement made by AVITA Medical, Inc. in September 2022 by COSMOTEC, an M3 Group Company.
- In February 2022, Avita Medical Inc., received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) in Japan to market the RECELL System in Japan.
- In April 2021, Sensus Healthcare announced the installation of its 500Th SRT unit.
Report Scope-Keloid Treatment Market
|
Attribute |
Details |
|
Estimated Market Size (2022) |
US$ 3.7 Bn |
|
Projected Market Size (2032) |
US$ 5.1 Bn |
|
Anticipated Growth Rate (2022-2032) |
3.2% |
|
Forecast Period |
2012-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, and South Africa |
|
Key Market Segments Covered |
Treatment, End User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market forecast, brand share analysis, competition intelligence, DROT analysis, market dynamics and challenges, strategic growth initiatives |
Key Market Segments Covered in Keloid Treatment Industry Research
By Treatment:
- Occlusive Dressing
- Compression Therapy
- Cryosurgery
- Excision
- Radiation Therapy
- Laser Therapy
- Interferon Therapy
- Intralesional Corticosteroid Injections
- Others
By End User:
- Hospitals
- Dermatology Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global keloid treatment market was valued at US$ 3.6 Bn in 2021 and is expected to reach US$ 3.7 Bn in 2022.
As per FMI, the global keloid treatment market is expected to register a CAGR of 3.2% between 2022 and 2032.
The global keloid treatment market is anticipated to reach a valuation of US$ 5.1 Bn by 2032.
Growing incidence of accidents and injury cases, surge in genetic and dermatological diseases, and the rising adoption of non-invasive procedures are some of the key trends shaping growth of the keloid treatment market.
The U.S., China, Japan, Brazil, and Germany are top 5 countries driving demand for the keloid treatments.
The U.S. accounted for about 88.0% of the North American keloid treatment market in 2021.
Demand for keloid treatment in Germany is expected to grow at 4.5% over the next ten years.
The U.S., China, and Japan are the key producers of keloid treatments.
Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, are some of the key players in the keloid treatment industry.
The keloid treatment market in China is set to expand at a CAGR of 3.6% over the forecast period.
The Japan keloid treatment market is set to expand at a CAGR of 2.9% over the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Treatment Innovation / Development Trends
4. Key Success Factors
4.1. Disease Prevalence
4.2. Promotional Strategies, By Key Manufacturers
4.3. Key Regulations
4.4. Value Chain Analysis
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Scar Treatment Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Incidence of Wound/Injury
5.2.2. Growing Adoption of Aesthetic Surgical Procedures
5.2.3. Rise in Medical Tourism
5.2.4. Introduction of Laser Therapy Devices
5.2.5. Development of Novel Therapeutic Formulations
5.2.6. Adoption of Radiation Therapy for Keloid Treatment
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Treatment
6.1.2. By End User
6.1.3. By Country
6.2. 2021 Market Scenario
7. Global Keloid Treatment Market - Pricing Analysis
7.1. Regional Pricing Analysis By Treatment
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Keloid Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032
8.1. Historical Market Value (US$ Mn) Analysis, 2012-2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Keloid Treatment Market Analysis 2012-2021 and Forecast 2022–2032, By Treatment
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2012 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2022 - 2032
9.3.1. Occlusive Dressing
9.3.2. Compression Therapy
9.3.3. Cryosurgery
9.3.4. Excision
9.3.5. Radiation Therapy
9.3.6. Laser Therapy
9.3.7. Interferon Therapy
9.3.8. Intralesional Corticosteroid Injections
9.3.9. Others
9.4. Market Attractiveness Analysis By Treatment
10. Global Keloid Treatment Market Analysis 2012-2021 and Forecast 2022–2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2012 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2032
10.3.1. Hospitals
10.3.2. Dermatology Clinics
10.3.3. ASCs
10.3.4. Others
10.4. Market Attractiveness Analysis By End User
11. Global Keloid Treatment Market Analysis 2012-2021 and Forecast 2022–2032, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Treatment
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment
12.4.3. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Keloid Treatment Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast By Market Taxonomy
12.8.1.2.1. By Country
12.8.1.2.2. By Treatment
12.8.1.2.3. By End User
12.8.2. Canada Keloid Treatment Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast By Market Taxonomy
12.8.2.2.1. By Country
12.8.2.2.2. By Treatment
12.8.2.2.3. By End User
13. Latin America Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.1.4.1. By Country
13.3.1.4.2. By Treatment
13.3.1.4.3. By End User
13.4. Market Attractiveness Analysis
13.4.1.1.1. By Country
13.4.1.1.2. By Treatment
13.4.1.1.3. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Keloid Treatment Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast By Market Taxonomy
13.8.1.2.1. By Treatment
13.8.1.2.2. By End User
13.8.2. Brazil Keloid Treatment Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast By Market Taxonomy
13.8.2.2.1. By Country
13.8.2.2.2. By Treatment
13.8.2.2.3. By End User
13.8.3. Argentina Keloid Treatment Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast By Market Taxonomy
13.8.3.2.1. By Treatment
13.8.3.2.2. By End User
14. Europe Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Nordic Countries
14.3.1.9. Rest of Europe
14.3.2. By Treatment
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Keloid Treatment Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Treatment
14.8.1.2.2. By End User
14.8.2. Italy Keloid Treatment Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Treatment
14.8.2.2.2. By End User
14.8.3. France Keloid Treatment Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast By Market Taxonomy
14.8.3.2.1. By Treatment
14.8.3.2.2. By End User
14.8.4. U.K. Keloid Treatment Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast By Market Taxonomy
14.8.4.2.1. By Treatment
14.8.4.2.2. By End User
14.8.5. Spain Keloid Treatment Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast By Market Taxonomy
14.8.5.2.1. By Treatment
14.8.5.2.2. By End User
14.8.6. BENELUX Keloid Treatment Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast By Market Taxonomy
14.8.6.2.1. By Treatment
14.8.6.2.2. By End User
14.8.7. Russia Keloid Treatment Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast By Market Taxonomy
14.8.7.2.1. By Treatment
14.8.7.2.2. By End User
14.8.8. Nordic Countries Keloid Treatment Market Analysis
14.8.8.1. Introduction
14.8.8.2. Market Analysis and Forecast By Market Taxonomy
14.8.8.2.1. By Treatment
14.8.8.2.2. By End User
15. East Asia Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Treatment
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Keloid Treatment Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Treatment
15.8.1.2.2. By End User
15.8.2. Japan Keloid Treatment Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Treatment
15.8.2.2.2. By End User
15.8.3. South Korea Keloid Treatment Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Treatment
15.8.3.2.2. By End User
16. South Asia Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Treatment
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Treatment
16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Keloid Treatment Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Treatment
16.8.1.2.2. By End User
16.8.2. Indonesia Keloid Treatment Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Treatment
16.8.2.2.2. By End User
16.8.3. Malaysia Keloid Treatment Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Treatment
16.8.3.2.2. By End User
16.8.4. Thailand Keloid Treatment Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast By Market Taxonomy
16.8.4.2.1. By Treatment
16.8.4.2.2. By End User
17. Oceania Keloid Treatment Market 2012-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Treatment
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Treatment
17.4.3. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Keloid Treatment Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast By Market Taxonomy
17.7.1.2.1. By Treatment
17.7.1.2.2. By End User
17.7.2. New Zealand Keloid Treatment Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast By Market Taxonomy
17.7.2.2.1. By Treatment
17.7.2.2.2. By End User
18. Middle East and Africa (MEA) Keloid Treatment Market Analysis 2012–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Treatment
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Treatment
18.4.3. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Keloid Treatment Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast By Market Taxonomy
18.8.1.2.1. By Treatment
18.8.1.2.2. By End User
18.8.2. Turkey Keloid Treatment Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast By Market Taxonomy
18.8.2.2.1. By Treatment
18.8.2.2.2. By End User
18.8.3. South Africa Keloid Treatment Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast By Market Taxonomy
18.8.3.2.1. By Treatment
18.8.3.2.2. By End User
18.8.4. North Africa Keloid Treatment Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast By Market Taxonomy
18.8.4.2.1. By Treatment
18.8.4.2.2. By End User
19. Market Structure Analysis
19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis (%) of Top Players
19.4. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Novartis AG
20.3.1.1. Overview
20.3.1.2. Treatment Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategic Overview
20.3.2. Sensus Healthcare
20.3.2.1. Overview
20.3.2.2. Treatment Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategic Overview
20.3.3. RXi Pharmaceuticals, Inc.
20.3.3.1. Overview
20.3.3.2. Treatment Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategic Overview
20.3.4. Sonoma Pharmaceuticals, Inc.
20.3.4.1. Overview
20.3.4.2. Treatment Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategic Overview
20.3.5. Perrigo Company plc.
20.3.5.1. Overview
20.3.5.2. Treatment Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategic Overview
20.3.6. Bristol-Myers Squibb Company
20.3.6.1. Overview
20.3.6.2. Treatment Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategic Overview
20.3.7. Pacific World Corporation
20.3.7.1. Overview
20.3.7.2. Treatment Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategic Overview
20.3.8. Valeant Pharmaceuticals International, Inc.
20.3.8.1. Overview
20.3.8.2. Treatment Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategic Overview
20.3.9. Revitol Corporation
20.3.9.1. Overview
20.3.9.2. Treatment Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategic Overview
20.3.10. Avita Medical Limited
20.3.10.1. Overview
20.3.10.2. Treatment Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategic Overview
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 02: Global Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 03: Global Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 04: Global Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 05: Global Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Region 2012-2021
Table 06: Global Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Region, 2022-2032
Table 07: North America Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021
Table 08: North America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 09: North America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 10: North America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 11: North America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 12: North America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 13: Latin America Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021
Table 14: Latin America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 15: Latin America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 16: Latin America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 17: Latin America Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 18: Latin America Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 19: Europe Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021
Table 20: Europe Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 21: Europe Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 22: Europe Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 23: Europe Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 24: Europe Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 25: South Asia Keloid Treatment Market Historical Market Value (US$ Mn) Analysis, By Country, 2012-2021
Table 26: South Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 27: South Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 28: South Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 29: South Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 30: South Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 31: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 32: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 33: East Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 34: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 35: East Asia Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 36: East Asia Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 37: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 38: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 39: Oceania Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 40: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 41: Oceania Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 42: Oceania Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Table 43: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 44: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Country, 2022-2032
Table 45: MEA Keloid Treatment Historical Market Value (US$ Mn) Analysis, By Treatment, 2012-2021
Table 46: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By Treatment, 2022-2032
Table 47: MEA Keloid Treatment Historical Market Value (US$ Mn) Analysis, By End User, 2012-2021
Table 48: MEA Keloid Treatment Current and Future Market Size (US$ Mn) Analysis, By End User, 2022-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 02: Global Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 03: Global Keloid Treatment Market Absolute $ Opportunity, 2022-2032
Figure 04: Global Keloid Treatment Market Share Analysis (%) By Treatment, 2022 & 2032
Figure 05: Global Keloid Treatment Market Y-o-Y Growth (%) By Treatment, 2022-2032
Figure 06: Global Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 07: Global Keloid Treatment Market Share Analysis (%) By End User, 2022 & 2032
Figure 08: Global Keloid Treatment Market Y-o-Y Growth (%) By End User, 2022-2032
Figure 09: Global Keloid Treatment Market Attractiveness Analysis, By End User
Figure 10: Global Keloid Treatment Market Share Analysis (%) By Region, 2022 & 2032
Figure 11: Global Keloid Treatment Market Y-o-Y Growth (%) By Region, 2022-2032
Figure 12: Global Keloid Treatment Market Attractiveness Analysis, By Region
Figure 13: North America Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 14: North America Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 15: North America Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 16: North America Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 17: North America Keloid Treatment Market Attractiveness Analysis, By Country
Figure 18: North America Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 19: North America Keloid Treatment Market Attractiveness Analysis, By End User
Figure 20: U.S. Market Value Proportion Analysis, 2022
Figure 21: Global Vs U.S. Y-o-Y Growth Comparison, 2021-2032
Figure 22: U.S. Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 23: U.S. Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 24: Canada Market Value Proportion Analysis, 2022
Figure 25: Global Vs Canada Y-o-Y Growth Comparison, 2021-2032
Figure 26: Canada Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 27: Canada Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 28: Latin America Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 29: Latin America Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 30: Latin America Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 31: Latin America Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 32: Latin America Keloid Treatment Market Attractiveness Analysis, By Country
Figure 33: Latin America Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 34: Latin America Keloid Treatment Market Attractiveness Analysis, By End User
Figure 35: Brazil Market Value Proportion Analysis, 2022
Figure 36: Global Vs Brazil Y-o-Y Growth Comparison, 2021-2032
Figure 37: Brazil Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 38: Brazil Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 39: Mexico Market Value Proportion Analysis, 2022
Figure 40: Global Vs Mexico Y-o-Y Growth Comparison, 2021-2032
Figure 41: Mexico Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 42: Mexico Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 43: Argentina Market Value Proportion Analysis, 2022
Figure 44: Global Vs Argentina Y-o-Y Growth Comparison, 2021-2032
Figure 45: Argentina Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 46: Argentina Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 47: Europe Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 48: Europe Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 49: Europe Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 50: Europe Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 51: Europe Keloid Treatment Market Attractiveness Analysis, By Country
Figure 52: Europe Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 53: Europe Keloid Treatment Market Attractiveness Analysis, By End User
Figure 54: U.K. Market Value Proportion Analysis, 2022
Figure 55: Global Vs U.K. Y-o-Y Growth Comparison, 2021-2032
Figure 56: U.K. Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 57: U.K. Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 58: Germany Market Value Proportion Analysis, 2022
Figure 59: Global Vs Germany Y-o-Y Growth Comparison, 2021-2032
Figure 60: Germany Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 61: Germany Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 62: Italy Market Value Proportion Analysis, 2022
Figure 63: Global Vs Italy Y-o-Y Growth Comparison, 2021-2032
Figure 64: Italy Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 65: Italy Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 66: France Market Value Proportion Analysis, 2022
Figure 67: Global Vs France Y-o-Y Growth Comparison, 2021-2032
Figure 68: France Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 69: France Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 70: Spain Market Value Proportion Analysis, 2022
Figure 71: Global Vs Spain Y-o-Y Growth Comparison, 2021-2032
Figure 72: Spain Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 73: Spain Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 74: Russia Market Value Proportion Analysis, 2022
Figure 75: Global Vs Russia Y-o-Y Growth Comparison, 2021-2032
Figure 76: Russia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 77: Russia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 78: Nordic Countries Market Value Proportion Analysis, 2022
Figure 79: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2021-2032
Figure 80: Nordic Countries Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 81: Nordic Countries Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 82: BENELUX Market Value Proportion Analysis, 2022
Figure 83: Global Vs BENELUX Y-o-Y Growth Comparison, 2021-2032
Figure 84: BENELUX Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 85: BENELUX Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 86: South Asia Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 87: South Asia Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 88: South Asia Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 89: South Asia Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 90: South Asia Keloid Treatment Market Attractiveness Analysis, By Country
Figure 91: South Asia Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 92: South Asia Keloid Treatment Market Attractiveness Analysis, By End User
Figure 93: India Market Value Proportion Analysis, 2022
Figure 94: Global Vs India Y-o-Y Growth Comparison, 2021-2032
Figure 95: India Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 96: India Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 97: Thailand Market Value Proportion Analysis, 2022
Figure 98: Global Vs Thailand Y-o-Y Growth Comparison, 2021-2032
Figure 99: Thailand Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 100: Thailand Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 101: Indonesia Market Value Proportion Analysis, 2022
Figure 102: Global Vs Indonesia Y-o-Y Growth Comparison, 2021-2032
Figure 103: Indonesia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 104: Indonesia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 105: Malaysia Market Value Proportion Analysis, 2022
Figure 106: Global Vs Malaysia Y-o-Y Growth Comparison, 2021-2032
Figure 107: Malaysia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 108: Malaysia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 109: East Asia Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 110: East Asia Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 111: East Asia Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 112: East Asia Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 113: East Asia Keloid Treatment Market Attractiveness Analysis, By Country
Figure 114: East Asia Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 115: East Asia Keloid Treatment Market Attractiveness Analysis, By End User
Figure 116: China Market Value Proportion Analysis, 2022
Figure 117: Global Vs China Y-o-Y Growth Comparison, 2021-2032
Figure 118: China Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 119: China Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 120: Japan Market Value Proportion Analysis, 2022
Figure 121: Global Vs Japan Y-o-Y Growth Comparison, 2021-2032
Figure 122: Japan Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 123: Japan Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 124: South Korea Market Value Proportion Analysis, 2022
Figure 125: Global Vs South Korea Y-o-Y Growth Comparison, 2021-2032
Figure 126: South Korea Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 127: South Korea Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 128: Oceania Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 129: Oceania Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 130: Oceania Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 131: Oceania Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 132: Oceania Keloid Treatment Market Attractiveness Analysis, By Country
Figure 133: Oceania Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 134: Oceania Keloid Treatment Market Attractiveness Analysis, By End User
Figure 135: Australia Market Value Proportion Analysis, 2022
Figure 136: Global Vs Australia Y-o-Y Growth Comparison, 2021-2032
Figure 137: Australia Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 138: Australia Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 139: New Zealand Market Value Proportion Analysis, 2022
Figure 140: Global Vs New Zealand Y-o-Y Growth Comparison, 2021-2032
Figure 141: New Zealand Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 142: New Zealand Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 143: Middle East and Africa (MEA) Keloid Treatment Market Value (US$ Mn) Analysis, 2022 & 2032, by Country
Figure 144: Middle East and Africa (MEA) Keloid Treatment Market Value (US$ Mn) Analysis, By Treatment, 2022
Figure 145: MEA Keloid Treatment Historical Market (US$ Mn) Analysis, 2012-2021
Figure 146: MEA Keloid Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2032
Figure 147: MEA Keloid Treatment Market Attractiveness Analysis, By Country
Figure 148: MEA Keloid Treatment Market Attractiveness Analysis, By Treatment
Figure 149: MEA Keloid Treatment Market Attractiveness Analysis, By End User
Figure 150: GCC Countries Market Value Proportion Analysis, 2022
Figure 151: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021-2032
Figure 152: GCC Countries Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 153: GCC Countries Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 154: Turkey Market Value Proportion Analysis, 2022
Figure 155: Global Vs Turkey Y-o-Y Growth Comparison, 2021-2032
Figure 156: Turkey Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 157: Turkey Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 158: North Africa Market Value Proportion Analysis, 2022
Figure 159: Global Vs North Africa Y-o-Y Growth Comparison, 2021-2032
Figure 160: North Africa Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 161: North Africa Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Figure 162: South Africa Market Value Proportion Analysis, 2022
Figure 163: Global Vs South Africa Y-o-Y Growth Comparison, 2021-2032
Figure 164: South Africa Keloid Treatment Market Share Analysis (%) By Treatment, 2021 & 2032
Figure 165: South Africa Keloid Treatment Market Share Analysis (%) by End User, 2021 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
